KolateAI PharmaTech Inc.
Biotechnology · Drug Discovery
Overview
Discover KolateAI's innovative platform that leverages AI and real-world data to optimize clinical trials and drug development. Empowering pharma companies with predictive insights for better decision-making.
Funding and backers
Backers
1
Entrepreneurs Roundtable Accelerator
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 24%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Theora, AbInitio Bio
backs Babylon
backs VeriSIM Life
backs Babylon
backs Babylon
backs Babylon
Similar startupsby what they do, their industry and backers
Analyst-grade AI system that answers complex questions across millions of references to optimize drug development and clinical trials.
Weatherden is a global drug development consultancy helping biotech and pharma realize the full potential of their science and investment.
Abinitio bio is the AI-native operating platform for drug development and manufacturing.
Psylink is a biotechnology company offering a novel solution to psychedelic drug development.
Babylon is a drug development company pursuing a transformational treatment for Alzheimer’s. Meet our team and explore how we discover…
Soricimed Biopharma is a clinical stage drug development company dedicated to novel trageted treatments for cancer.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Entrepreneurs Roundtable AcceleratorVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
NYC's (ERA) Entrepreneurs Roundtable Accelerator Announces Participants For Its Winter 2024 Program; Companies Receive $150,000 Investments On a Post-Money SAFE
New York-January 8, 2024-ERA today announced that it has selected its Winter 2024 class. The companies selected to participate in the four-month program are innovating in a variety of significant industries, all with businesses ready to take advantage of
Read more
Report